Novora BioMedical Corporation

Novora BioMedical Corporation

June 16, 2010 09:28 ET

Three World-Class Scientists Join Novora BioMedical Corporation™

TORONTO, ONTARIO--(Marketwire - June 16, 2010) - Novora BioMedical Corporation™ ('Novora™' or the 'company') announced the addition of three pre-eminent scientists to the company's Scientific Advisory Board today. Joining the Toronto based company are Dr. Walter Loesche, Dr. Dennis Cvitkovitch and Mr. Dean Swift. Each is a world-renowned expert in their respective fields.

Dr. Loesche is the Marcus Ward Professor Emeritus at the School of Dentistry and Professor Emeritus, Department of Microbiology and Immunology at the School of Medicine, University of Michigan. He is the past president of the American Association for Dental Research, and holds degrees from both Harvard University and the Massachusetts Institute of Technology.

Dr. Cvitkovitch is a Professor of Oral Microbiology, Director of the Dental Research Institute at the University of Toronto and the Associate Dean of Research at the University's Faculty of Dentistry. He is also the Canada Research Chair in Biofilm Physiology and Genetics.

Mr. Dean Swift is the Research Director at Biolennia Laboratories as well as the founder and CEO of Micryllium Laboratories. Micryllium Laboratories is a multipurpose research and an ISO 9001 manufacturing facility that provides infection control expertise and products to the dental and medical professions.

Novora™ is a company that specializes in providing dental health professionals with microbiology and bacteriology diagnostics, treatment protocols and specialized practice management to address the burgeoning professional and public awareness of the link between oral health and overall health.

Dr. Loesche sums up Novora's mission; " Bacterial screening and laboratory testing should be the standards of care to permit selection of appropriate topical and/or systemic antimicrobial therapy targeted at eliminating the oral infections, responsible for periodontal disease, dental decay and numerous systemic conditions."

Novora's founder and CEO Dr. Steven Small says, "The addition of Dr. Loesche, Dr. Cvitkovitch and Mr. Swift is a phenomenal validation of our young company. Having such esteemed researchers on our Scientific Advisory Board not only establishes and reinforces our credibility, but also positions the company to increase the scope and quality of its service offerings."

About Novora BioMedical Corporation™

Novora™ is a Canadian based biomedical and targeted practice management company for the professional dental industry. The company provides services, products and targeted consulting as they relate to integrating the Oral-Systemic Link into the dental practice. Novora™ is also expanding into research and design of new products and diagnostics as they relate to dental and periodontal treatment.

Contact Information